Neurodegenerative Diseases News and Research

RSS

UK charity invests £1 million to develop potential therapeutic for Parkinson's

Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.

1 Jul 2019

Cutting-edge electron microscopy reveals first structures of a lipid-flippase

Using cutting-edge electron microscopy, researchers from Aarhus University have determined the first structures of a lipid-flippase.

29 Jun 2019

Scientists discover pathway that prevents buildup of Alzheimer's protein

St. Jude Children's Research Hospital scientists have discovered a pathway that functions like a car wash to prevent the buildup of a toxic protein associated with Alzheimer's disease. The report appeared online today in the journal Cell.

28 Jun 2019

Long-term statin use linked to lower risk of glaucoma

The long-term use of statins, drugs that control elevated cholesterol levels, has been linked to a lower risk of developing glaucoma, a new study suggests.

27 Jun 2019

Sleep decline in one's 50s, 60s increases risk of Alzheimer's disease

People who report a declining quality of sleep as they age from their 50s to their 60s have more protein tangles in their brain, putting them at higher risk of developing Alzheimer's disease later in life, according to a new study by psychologists at the University of California, Berkeley.

27 Jun 2019

Researchers challenge conventional understanding of cause of Parkinson's

An international team of researchers involving members of the University of Basel's Biozentrum challenges the conventional understanding of the cause of Parkinson's disease.

26 Jun 2019

New blood test could potentially diagnose Alzheimers even before symptoms appear

Doctors may one day be able to diagnose Alzheimer's disease, the most common cause of severe dementia, and monitor a patient's response to treatment by doing a simple blood test.

24 Jun 2019

Largest study finds CTE in 6% of athletes and non-athletes

Nearly 6% of athletes and non-athletes were found to have the neurodegenerative disorder chronic traumatic encephalopathy in the largest, and broadest, study conducted of the disease to date.

23 Jun 2019

Anti-aging study wins grant from William and Ella Owens Medical Research Foundation

The William and Ella Owens Medical Research Foundation has awarded Texas Biomed Associate Professor Marcel Daadi, Ph.D., with a grant of more than $100,000 to test a promising FDA-approved drug for reversing age-related cognitive decline and memory deficits observed in aged baboons.

18 Jun 2019

Canadian Institutes of Health Research and partners fund CCNA's second phase

Thanks to a $46-million investment from the Canadian Institutes of Health Research (CIHR) and other funding partners, the Canadian Consortium on Neurodegeneration in Aging (CCNA) will be renewed for a second phase, announced today.

17 Jun 2019

Researchers reveal underlying mechanism that protects genetic transcripts in cells

The cell contains transcripts of the genetic material, which migrate from the cell nucleus to another part of the cell. This movement protects the genetic transcripts from the recruitment of "spliceosomes".

13 Jun 2019

Study aims at developing new therapies to fight childhood cancer

Researchers from the Department of Cellular Biology at the University of Seville and the Seville Institute of Biomedicine, Pablo Vicente and Doctor Luisma Escudero, in close collaboration with the researcher Rebecca Burgos and other members of the group of Doctor Rosa Noguera have published a study aimed at developing new therapies to fight childhood cancer.

12 Jun 2019

URMC biotech start-up receives funding to develop cell-based therapies for neurological disorders

Oscine Therapeutics, a new biotechnology company based on discoveries made and developed at the University of Rochester Medical Center has received a significant multi-year investment to support both research and development of cell-based therapies for neurological disorders.

11 Jun 2019

Researchers propose a new look at the role of ferroptosis in cancer development

Professor of Ghent University and Lead Researcher at the Institute of Biology and Biomedicine of the Lobachevsky University Dmitri Krysko together with scientists from Germany, Professor Marcus Conrad and Professor Jose Pedro Friedmann Angeli recently published an article in the journal Nature Reviews Cancer, one of the highest-rated journals that occupies the 2nd line in the oncology section among 223 journals in this category and has an impact factor of 42.78 according to WoS data.

7 Jun 2019

Nanotechnology treatment reverses multiple sclerosis symptoms in mice

A nanotechnology treatment derived from bone marrow stem cells has reversed multiple sclerosis symptoms in mice and could eventually be used to help humans, according to a new study led by University of California, Irvine researchers.

6 Jun 2019

Researchers determine 3D structure of proteins inside living eukaryotic cells

Researchers from Tokyo Metropolitan University have successfully determined the high-resolution three-dimensional structure of proteins inside living eukaryotic cells.

3 Jun 2019

Study searches for the origins of depressive symptoms in Huntington's disease

About 40% of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.

31 May 2019

Racism is toxic to humans, study shows

A new study indicates that racism is toxic to humans. A team of USC and UCLA scientists found that racist experiences appear to increase inflammation in African American individuals, raising their risk of chronic illness, according to the study published in the journal Psychoneuroendocrinology on April 18.

31 May 2019

Study sheds light on design of pharmacological strategies to treat depression in Huntington's disease

About 40 % of the affected patients with Huntington's disease -a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of the typical motor symptoms of the disease.

31 May 2019

Study uncovers how simpler organisms manage recycling of incomplete proteins

Our cells' process for transforming genes into useful proteins works much like an automobile factory's assembly line; there are schematics, parts, workers, motors, quality control systems and even recycling crews.

31 May 2019